Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride significantly reduced sperm production and caused testicular atrophy in hamsters.

Heart-specific steroid metabolism is crucial in cardiac hypertrophy.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

High-dose testosterone with finasteride improves muscle health in males with spinal cord injury.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Taking medication for hair loss might cause sexual problems.

Transplanted hair follicles can improve and remodel mature scars.

Different types of skin cells create unique support structures that can affect skin cell growth and could help in skin repair.

Targeting adipocyte-to-mesenchymal transition could help treat fibrosis.

A woman had eye pain and vision loss after a hair growth treatment, but her symptoms improved after a month.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

The patient with EEC syndrome had scarring alopecia due to deep folliculitis, possibly linked to abnormal hair structure.

The model helps understand scar contraction and develop new treatments.

Understanding the nanoscale structure of skin fibrosis can improve knowledge of wound healing and tissue regeneration.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Finasteride significantly reduces fertility in male rats.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

AMT may cause hair loss and changing dWAT activity could help treat it.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

The woman's widespread skin condition did not improve despite various treatments.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Diagonal earlobe and preauricular creases may indicate higher coronary artery disease risk in men.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.